Follow The Filings

GENB Generate Biomedicines Inc.

Health Care, filed as GENERATE BIOMEDICINES INC (COM SHS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $22M
  • 1 add

In 2026 Q2 Cathie Wood added to Generate Biomedicines.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Cathie Wood, Ark Investment Management). Not free-float ownership.

  1. Cathie Wood Add 0.14%

Who owns GENB

Sorted by value, long equity only, as of 2026 Q2.

History
Cathie Wood, Ark Investment Management 0.14%, was 0.05% Add +157.7% 1,284,617 $22M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GENB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GENB insider trades
  • $150M bought by 5 insiders
  • None no sales outside a trading plan
  • $16K sold by 1 insider under 10b5-1 plans
  1. Frances Arnold Director
    Planned sale
    $16K 1,000 shares at $16.00 0.4% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  2. Michael Nally CEO
    Buy
    $240K 20,000 shares at $12.00 +3.6% to stake
    Traded Mar 4 Filed Mar 6
    ↗
  3. Beth Grous Chief People Officer
    Buy
    $4,800 300 shares at $16.00 New stake
    Traded Mar 2 Filed Mar 2
    ↗
  4. Jason Silvers CFO
    Buy
    $32K 2,000 shares at $16.00 New stake
    Traded Mar 2 Filed Mar 2
    ↗
  5. Noubar Afeyan Director, +7 joint filers
    Buy
    $75M 4,687,500 shares at $16.00 New stake
    Traded Mar 2 Filed Mar 2
    ↗
  6. Jane L Mendillo Director
    Buy
    $24K 1,500 shares at $16.00 New stake
    Traded Mar 2 Filed Mar 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 conversions.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.03,9.01 Filing Doc
424B4 Filing Doc
S-1/A Filing Doc
S-1/A Filing Doc
S-1 Filing Doc

Source: SEC EDGAR submissions, updated about 17 hours ago. All on EDGAR

Financials

US-GAAP annual figures, as tagged in Form 10-K

Newly public, no 10-K financials yet. See the S-1/A.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.